Lobo Genetics DNA testing platform for safer cannabis use
Lobo Genetics multi-platform direct-to-consumer DNA testing platform enables safer cannabis use through DNA testing. Consumers and patients can gain actionable insights into their personal responses to cannabis based on their genetic profiles.
My role
As the director of product management of Lobo genetics, I worked with our multidisciplinary team to expand the product vision from a DNA testing site to a rich source of information and go-to platform for Cannabis genetic testing. I conducted research, and user interviews, managed customer onboarding, oversaw the development and worked closely with the CEO and lead engineer.
As the product owner of the Lobo team, I had additional responsibilities including running marketing campaigns and aiding in business development.
My responsibilities extended to coordinating a diverse remote team that spanned timezones.
PRODUCT
We embarked on building out the Cannabis DNA testing platform and also building out a product team to try and figure out what sort of innovations, and what sort of technologies we would want to use to radically improve the legal cannabis experience.
Cannabis genetic testing service uses Polymerase Chain Reaction (PCR) technology, which is a well-established method for genotyping and analyzing DNA. Customer sample is handled and processed at Lobo’s testing facility using the advanced Lobo Cube testing platform, in a controlled environment.
The complete vision for the platform is made up of three major aspects :
1. public site to offer the test kit,
2. lab interface used by Lobo’s scientists,
3. consumer portal for users to receive their personalized reports.
Acquisition
Lobo Genetics was acquired in 2021 by Entheon biomedical corp., a pioneer in drug development and Mental health research.
